Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Non-Resectable Hepatocellular Carcinoma

A hepatocellular carcinoma that is not amenable to surgical resection.
National Institutes of Health

Related topics

Related topics

22 relations
Abdominal PainAberrant DNA MethylationBile Ducts, ExtrahepaticChromosome 13q deletion
Expand

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Metabolic liver function after stereotactic body radiation therapy for hepatocellular carcinoma
Abstract Purpose The time course of changes of the liver function after stereotactic body radiotherapy (SBRT) was analyzed in… Expand
Is this relevant?
2015
2015
Adjuvant stereotactic body radiotherapy following transarterial chemoembolization in patients with non-resectable hepatocellular carcinoma tumours of ≥ 3 cm.
OBJECTIVES The optimal locoregional treatment for non-resectable hepatocellular carcinoma (HCC) of ≥ 3 cm in diameter is unclear… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 3
Is this relevant?
2013
2013
Integrating sorafenib into an algorithm for the management of post-transplant hepatocellular carcinoma recurrence.
Since the introduction of the Milan criteria in 1996, liver transplantation has become the best treatment option for many… Expand
  • figure 1
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Stereotactic body radiation therapy with or without transarterial chemoembolization for patients with primary hepatocellular carcinoma: preliminary analysis
BackgroundThe objectives of this retrospective study was to evaluate the efficacy of stereotactic body radiation therapy (SBRT… Expand
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2008
2008
Prognostic factors of survival in patients with non-resectable hepatocellular carcinoma: hepatitis C versus miscellaneous etiology.
OBJECTIVE To identify prognostic determinants of survival in patients with non-resectable hepatocellular carcinoma (HCC… Expand
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2007
2007
Transarterial chemoembolization using degradable starch microspheres and iodized oil in the treatment of advanced hepatocellular carcinoma: evaluation of tumor response, toxicity, and survival.
BACKGROUND In a multidisciplinary conference patients with advanced non-resectable hepatocellular carcinoma (HCC) were stratified… Expand
Is this relevant?
1993
1993
Palliative surgical treatment for recurrent and non-resectable hepatocellular carcinoma.
Of 275 patients who had a radical hepatic resection for HCC, 143 (52%) experienced recurrences. Of these 143 patients, the liver… Expand
Is this relevant?
1990
1990
[Lipiodol transcatheter arterial chemoembolization for non-resectable hepatocellular carcinoma--multicenter cooperative study].
A cooperative group study was carried out on the effect of Lipiodol transcatheter arterial chemo-embolization (L-TACE) for non… Expand
Is this relevant?
1989
1989
Arterial chemotherapy and transcatheter arterial embolization therapy for non-resectable hepatocellular carcinoma
SummaryAn assessment was made on the therapeutic effects of arterial chemotherapy and transcatheter arterial embolization (TAE… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
1986
1986
[Intra-arterial administration of epirubicin in the treatment of non-resectable hepatocellular carcinoma. Epirubicin Study Group for Hepatocellular Carcinoma].
A group study was conducted to investigate the effect of intra-hepatic arterial administration of epirubicin in the treatment of… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE